Mortgage Rates Remain Stubbornly High Despite Fed Rate Cut Whats Behind the Divergence Trump Rejects Iran Counterproposal Prolonging Strait of Hormuz Standoff and Energy Market Volatility SpaceX and OpenAI MegaIPOs Could Signal Market Peak Analysts Suggest Singapore High Court Criticizes UOB Over Inconsistent Legal Positions in Mortgage Dispute Norway Accelerates Oil and Gas Expansion Amid Europes Energy Security Push FourTime F1 Champion Alain Prost Injured in Masked Gang Raid Near Geneva Kimball Electronics Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Rise TIGO Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines 33 Lyell Immunopharma Q1 2026 Earnings Narrower Loss Surprises Expectations Amid Clinical Progress FROG Q1 2026 Earnings Strong Earnings Beat Drives Shares Higher Guidance in Focus CMMB Q1 2026 Earnings WiderthanExpected Loss No Revenue Stock Rises 233 GRNT Q1 2026 Earnings Granite Ridge Resources Misses Big as EPS Falls 84 Below Consensus Banco Santander Chile BSAC Shows Mild Pullback After Recent Gains Psyence Biomedical Warrants PBMWW Edge Higher Support and Resistance Converge at 003 Translational Development Acquisition Corp TDAC Edges Lower Consolidates Near Key Support Republic Digital Acquisition Company Unit RDAGU Holds Steady at 1055 Amid Neutral Trading Dorman Products Gains Ground Approaches Resistance as Aftermarket Demand Holds Steady Arabica Coffee Prices Surge to Record High After USColombia Tariff Tensions Ease Immunome Inc Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue Stock Slips Quanterix QTRX Rallies 189 as Shares Test Key Resistance Near 282 Gentherm Inc THRM Q1 2026 Earnings EPS Crushes Estimates Stock Rises WATT Q1 2026 Earnings EPS Surprise of 3464 Despite No Revenue Stock Declines CVI Q1 2026 Earnings Significant EPS Miss Amidst Challenging Refining Environment AMD Q1 2026 Earnings EPS Beats Estimates by Nearly 5 Stock Surges Over 7 CRS Q1 2026 Earnings EPS Beats Estimates by 408 Stock Shows Modest Uptick HTHT Q1 2026 Earnings Slight EPS Miss Amidst Modest Stock Decline Actinium Pharmaceuticals ATNM Q1 2026 Earnings Narrower Loss Beats Expectations as Development Pipeline Advances